PSEUDOLYMPHOMA side effect
What is PSEUDOLYMPHOMA ?Drugs associated with PSEUDOLYMPHOMA
COUMADIN DEPAKENE EFALIZUMAB HUMIRA LAMICTAL LEUCOVORIN TEGRETOLPSEUDOLYMPHOMA : Humira Side Effects Report #5629948-7
Physician from SWITZERLAND reported HUMIRA problem on Feb 11, 2008. Female patient, weighting 165.3 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: pseudolymphoma, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, ANTIHYPERTENSIVES. Patient recovered.
PSEUDOLYMPHOMA : Humira Side Effects Report #5619100-3
HUMIRA problem was reported by a Physician from SWITZERLAND on Feb 01, 2008. Female patient, 57 years of age, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: benign lymph node neoplasm, pseudolymphoma, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, FOLIC ACID, ANTIHYPERTENSIVES. Patient recovered.
PSEUDOLYMPHOMA : Depakene Side Effects Report #5645730-9
Health Professional from FRANCE reported DEPAKENE problem on Feb 21, 2008. Male patient was diagnosed with epilepsy and was treated with DEPAKENE. After drug was administered, patient experienced the following problems/side effects: perivascular dermatitis, pseudolymphoma, . DEPAKENE dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, LEVETIRACETAM. Patient recovered.
PSEUDOLYMPHOMA : Leucovorin Side Effects Report #5599877-6
LEUCOVORIN CALCIUM problem was reported by a Health Professional from ITALY on Jan 08, 2008. Male patient, 66 years of age, was diagnosed with colon cancer metastatic, metastases to liver, metastases to lung and was treated with LEUCOVORIN CALCIUM. After drug was administered, patient experienced the following problems/side effects: lymphoid tissue hyperplasia, pseudolymphoma, rash, . LEUCOVORIN CALCIUM dosage: unknown. During the same period patient was treated with LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, FLUOROURACIL, OXALIPLATIN. Patient recovered.
PSEUDOLYMPHOMA : Coumadin Side Effects Report #5411436-4
Physician from FRANCE reported COUMADIN problem on Aug 08, 2007. Female patient, 76 years of age, was diagnosed with atrial fibrillation, hypertension, bone pain and was treated with COUMADIN. After drug was administered, patient experienced the following problems/side effects: pruritus, pseudolymphoma, rash papular, . COUMADIN dosage: unknown. During the same period patient was treated with MEDIATENSYL, HYDERGINE, AMIODARONE, ACETAMINOPHEN AND TRAMADOL, SIMVASTATIN, KARDEGIC, RABEPRAZOLE. Patient was hospitalized. Patient recovered.
PSEUDOLYMPHOMA : Lamictal Side Effects Report #5412501-8
LAMICTAL problem was reported by a Physician from CANADA on Aug 03, 2007. Female patient, 61 years of age, was diagnosed with bipolar disorder and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: lymphoid tissue hyperplasia, pseudolymphoma, rash macular, . LAMICTAL dosage: 100MG TWICE PER DAY. During the same period patient was treated with QUETIAPINE FUMARATE, ADVIL LIQUI, NAPROSYN. Patient recovered.
PSEUDOLYMPHOMA : Efalizumab Side Effects Report #5669947-2
Health Professional from SWITZERLAND reported EFALIZUMAB problem on Mar 04, 2008. Female patient was diagnosed with psoriasis and was treated with EFALIZUMAB. After drug was administered, patient experienced the following problems/side effects: herpes zoster, lymphadenopathy, pseudolymphoma, . EFALIZUMAB dosage: 0.8 ML, 1/WEEK. Patient was hospitalized. Patient recovered.
PSEUDOLYMPHOMA : Tegretol Side Effects Report #5630235-1
TEGRETOL problem was reported by a Consumer or non-health professional from FRANCE on Feb 12, 2008. Male patient, 39 years of age, was diagnosed with epilepsy and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: biopsy skin, lymphocytic infiltration, pseudolymphoma, skin lesion, . TEGRETOL dosage: 500 MG, BID. During the same period patient was treated with DEPAKENE, KEPPRA. Patient recovered.